Pharmacology of imatinib (STI571)
Year: 2002
Type: review
Source: European Journal of Cancer
Institution: Novartis (Switzerland)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: imatinib, tyrosine kinase inhibitors, BCR-ABL, chronic myeloid leukemia, PDGF receptor, angiogenesis inhibition, vascular endothelial growth factor, basic fibroblast growth factor, gastrointestinal stromal tumor, KIT receptor, small cell lung cancer, dermatofibrosarcoma protuberans, glioblastoma, chronic myelomonocytic leukemia, bone metastasis, interstitial fluid pressure, colon cancer, anticancer activity
Open Access status: closed
OpenAlex ID: W2064062041
